Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Trial Name: A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer.
Protocol ID: NSABP B49
Unstable diabetes mellitus.
Enrollment: 1843 women
Taking part in this study may or may not make your health better. While doctors hope that the combination of docetaxel and cyclophosphamide is as good as the other combinations of standard chemotherapy for treating breast cancer, there is no proof of this yet. The information from this study could help future breast cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.
Created: Jan 18, 2013
Updated: Jan 18, 2013